Thrombosis Research

Papers
(The H4-Index of Thrombosis Research is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells48
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms48
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis38
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients37
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination36
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion35
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients35
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study35
Editorial Board34
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]33
Regulation of fibrinogen synthesis32
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis30
DOACs: A perfect fit for patients with bariatric surgery?29
A novel role of acellular hemoglobin in hemolytic thrombosis29
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers29
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study29
Impact of aetiology and liver stiffness on thrombin generation in compensated cirrhosis28
The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum26
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban26
Thrombosis after surgical splenectomy – why, in whom and can we prevent it?26
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease25
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review25
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice24
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs24
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort24
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura24
Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry24
Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial rep24
0.13132309913635